19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Immunoglobulin A nephropathy (IgAN), membranous nephropathy (MN) and minimal-change disease (MCD) are three common types of glomerulonephritis in China. Pathological diagnosis based on renal biopsy is the criterion and the golden standard for diagnosing the sub-types of primary or secondary glomerulonephritis. Immunoglobulin and complements might be used in the differential diagnosis of glomerulonephritis without renal biopsies. However, the relationship between IF intensities of immune proteins and the corresponding serum levels remained unclear, and seldom studies combine histopathological examination results and blood tests together for a predictive purpose. This study was considered as a pilot study for integrating histopathological indicators into serum parameters for exploring the relationship of IF intensity and serum values of immunoglobulin and complement, and for screening and investigating effective indicators inIgAN, MN and MCD.

          Methods

          Renal tissue immunofluorescence (IF) intensity grades and serum levels of immunoglobulin and complements (IgG, IgA, IgM, C3 and C4) were retrospectively analyzed in 236 cases with IgAN, MN or MCD. IF grades were grouped as negative (−), positive (+) or strong positive (++) with both high and low magnification of microscope. Other serum indicators such as urea nitrogen (BUN), creatinine (Crea) and estimated glomerular filtration rate (eGFR) were also evaluated among the groups.

          Results

          There were difference in IgA, IgG and C3 IF intensity grades among IgAN, MN and MCD groups ( p = 9.82E-43, 4.60E-39, 7.45E-15, respectively). Serum values of BUN, Crea, eGFR, IgG, IgA, IgM and C4 showed difference in three groups (BUN: p = 0.045, Crea: p = 3.45E-5, eGFR: p = 0.005, IgG: p = 1.68E-14, IgA: p = 9.14E-9, IgM: p = 0.014, C4: p = 0.026). eGFR had the trend to decrease with enhanced IgA IF positive grades ( p = 8.99E-4); Crea had trends to decrease with both enhanced IgA and IgG IF intensity grades ( p = 2.06E-6, 2.94E-5, respectively). In all subjects, serum IgA levels was inversely correlated with eGFR( r = − 0.216, p = 0.001) and correlated with Crea levels( r = 0.189, p = 0.004); serum IgG and Crea showed no correlation which were discordance with inverse correlation of IgG IF grade and Crea( r = 0.058, p = 0.379). IgG serum level was inverse correlated with its IF grades ( p = 3.54E-5, p = 7.08E-6, respectively); C3 serum levels had significantly difference between Neg and positive (+) group ( p = 0.0003). IgA serum level was positive correlated with its IF grades (Neg-(+): p = 0.0001; (+)-(++): p = 0.022; Neg-(++): p = 2.01E-10). After matching comparison among C3 groups, C3 Neg. group and C3 ++ group had difference (* p = 0.017). C4 had all negative IF expression in all pathological groups. In IgAN subjects, there were statistical differences of serum C3 levels between its pathological Neg and positive (+) group( p = 0.026), and serum IgA levels showed difference between IgA pathological positive(+) and (++)( p = 0.007). In MN subjects, sIgG levels showed difference between IgG pathological IF grade positive (+) and (++)( p = 0.044); serum C3 levels showed difference between C3 pathological IF grade Neg and positive(+)( p = 0.005); and serum IgA levels showed difference between Neg and positive(+)( p = 0.040). In IgAN, eGFR showed serum IgA levels had significant differences among groups ( p = 0.007) and had increasing trend with enhanced its IF grades(P trend = 0.016). There were also difference between IgG group Neg and positive (+) ( p = 0.005, P trend = 0.007) in IgAN. In MN, serum IgG levels had significant differences among IF groups ( p = 0.034) and had decreasing trend with its enhanced IF grades (P trend = 0.014). Serum C3 concentrations also were found distinctive among IF groups ( p = 0.016) and had in inverse correlation with its enhanced IF grades (P trend = 0.004).

          Discussion

          Our research cross contrasts several immunoprotein IF intensities and relevant serum levels in three kinds of primary glomerular nephritis, and finally acquired helpful results for understanding the relationships between pathological presentation and serological presentation of immunoproteins in kidney diseases. Furthermore, this pilot study is offering a possible method for the analysis of combination of pathology and serology.

          Conclusion

          Different pathological types of nephritis presented different expression patterns of immunoglobulin and complement, especially IgA and IgG, which suggested different pathogenesis involved in the development of IgAN and MN. Furthermore, either in tissue or in serum, increased IgA level was closely related with renal function in all of the patients.

          Electronic supplementary material

          The online version of this article (10.1186/s12865-018-0254-z) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Big data for health.

          This paper provides an overview of recent developments in big data in the context of biomedical and health informatics. It outlines the key characteristics of big data and how medical and health informatics, translational bioinformatics, sensor informatics, and imaging informatics will benefit from an integrated approach of piecing together different aspects of personalized information from a diverse range of data sources, both structured and unstructured, covering genomics, proteomics, metabolomics, as well as imaging, clinical diagnosis, and long-term continuous physiological sensing of an individual. It is expected that recent advances in big data will expand our knowledge for testing new hypotheses about disease management from diagnosis to prevention to personalized treatment. The rise of big data, however, also raises challenges in terms of privacy, security, data ownership, data stewardship, and governance. This paper discusses some of the existing activities and future opportunities related to big data for health, outlining some of the key underlying issues that need to be tackled.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Primary glomerulonephritides

            Most glomerulonephritides, even the more common types, are rare diseases. They are nevertheless important since they frequently affect young people, often cannot be cured, and can lead to chronic kidney disease, including end-stage renal failure, with associated morbidity and cost. For example, in young adults, IgA nephropathy is the most common cause of end-stage renal disease. In this Seminar, we summarise existing knowledge of clinical signs, pathogenesis, prognosis, and treatment of glomerulonephritides, with a particular focus on data published between 2008 and 2015, and the most common European glomerulonephritis types, namely IgA nephropathy, membranous glomerulonephritis, minimal change disease, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis, and the rare complement-associated glomerulonephritides such as dense deposit disease and C3 glomerulonephritis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pathogenesis of IgA nephropathy.

              Since its first description in 1968, IgA nephropathy has remained the most common form of idiopathic glomerulonephritis leading to chronic kidney disease in developed countries. The exact pathogenesis of IgA nephropathy is still not well defined. Current data implicate an important genetic factor, especially in promoting the overproduction of an aberrant form of IgA1. The immunochemical aberrancy of IgA nephropathy is characterized by the undergalactosylation of O-glycans in the hinge region of IgA1. However, such aberrant glycosylation alone does not cause renal injury. The next stage of disease development requires the formation of glycan-specific IgG and IgA antibodies that recognize the undergalactosylated IgA1 molecule. These antibodies often have reactivity against antigens from extrinsic microorganisms and might arise from recurrent mucosal infection. B cells that respond to mucosal infections, particularly tonsillitis, might produce the nephritogenic IgA1 molecule. With increased immune-complex formation and decreased clearance owing to reduced uptake by the liver, IgA1 binds to the glomerular mesangium via an as yet unidentified receptor. Glomerular IgA1 deposits trigger the local production of cytokines and growth factors, leading to the activation of mesangial cells and the complement system. Emerging data suggest that mesangial-derived mediators following glomerular deposition of IgA1 lead to podocyte and tubulointerstitial injury via mesangio-podocytic-tubular crosstalk. This Review summarizes the latest findings in the pathogenesis of IgA nephropathy.
                Bookmark

                Author and article information

                Contributors
                wangyong301@263.net
                Journal
                BMC Immunol
                BMC Immunol
                BMC Immunology
                BioMed Central (London )
                1471-2172
                20 June 2018
                20 June 2018
                2018
                : 19
                : 18
                Affiliations
                [1 ]ISNI 0000 0004 1761 8894, GRID grid.414252.4, Department of Clinical Biochemistry, , Medical Laboratory Center, State Key Laboratory of Kidney Disease, Chinese PLA General Hospital, ; Beijing, 100853 China
                [2 ]ISNI 0000 0004 1761 8894, GRID grid.414252.4, Testing Center of Health Management Institute, Chinese PLA General Hospital, ; Beijing, 100853 China
                [3 ]ISNI 0000 0004 1761 8894, GRID grid.414252.4, Department of Nephrology, , Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Medical Institution Conducting Clinical Trials, Chinese PLA General Hospital, ; Beijing, China
                Author information
                http://orcid.org/0000-0001-9571-760X
                Article
                254
                10.1186/s12865-018-0254-z
                6011399
                29925312
                ad2e38ff-b464-4a2a-ad47-0bab999b315c
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 7 February 2018
                : 7 June 2018
                Funding
                Funded by: Young science foundation of National Natural Science Foundation of China
                Award ID: 81401719
                Funded by: Chinese national 863 project
                Award ID: 2014AA022304
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Immunology
                immunoglobulin a nephropathy,membranous nephropathy,minimal change disease,immunoglobulin,complement

                Comments

                Comment on this article